Approval · Notice of Compliance 12782 · 2011
EFRACEA: Notice of Compliance 12782
Issued November 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12782
- Date
- November 14, 2011
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anti-rosacea
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EFRACEA | 02375885 | Marketed |
Medicinal ingredients
- DOXYCYCLINE 40 MG per CAP